ProShare Advisors’s ASP Isotopes ASPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$94.9K Sell
15,251
-1,230
-7% -$7.24K ﹤0.01% 1780
2026
Q1
$72.8K Sell
16,481
-423
-3% -$2.5K ﹤0.01% 1750
2025
Q4
$90.4K Buy
16,904
+3,803
+29% +$30.2K ﹤0.01% 1890
2025
Q3
$126K Buy
13,101
+1,448
+12% +$13.4K ﹤0.01% 1798
2025
Q2
$85.8K Sell
11,653
-177
-1% -$1.19K ﹤0.01% 1902
2025
Q1
$55.5K Sell
11,830
-2,921
-20% -$14.6K ﹤0.01% 1941
2024
Q4
$66.8K Buy
+14,751
New +$78.5K ﹤0.01% 2143

Other funds holding ASPI

ProShare Advisors's ASPI Position: Q2 2026 in Review

ProShare Advisors reduced its ASP Isotopes (ASPI) stake by 7.5% in Q2 2026, selling an estimated $7.24K and leaving 15,251 shares worth $94.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1780.

ProShare Advisors first reported a position in ASPI in Q4 2024 and has held it in 7 quarters since. The position peaked at $126K in Q3 2025. 185 funds tracked by Wall St. Rank hold ASPI as of Q2 2026.

  • ProShare Advisors held 15,251 shares of ASP Isotopes worth $94.9K as of Q2 2026.
  • ProShare Advisors sold 1,230 ASP Isotopes shares in Q2 2026, an estimated $7.24K.
  • ASP Isotopes made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1780 holding.
  • ProShare Advisors first reported a position in ASP Isotopes in Q4 2024 and has held it in 7 quarters since.
  • ProShare Advisors's ASP Isotopes position peaked at $126K in Q3 2025.
  • 185 funds tracked by Wall St. Rank held ASP Isotopes as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.